Enhancement of sexual behavior in the female rat by nicotine

Prepubescent Electronic Cigarette Exposure Affects Sexual Motivation and Puberty in Female But Not Male Long-Evans Rats

INTRODUCTION

A method for delivering vaporized nicotine to animals has been developed using e-cigarette devices. The present experiment was designed to measure the effects of e-cigarette nicotine on pubertal onset and development of reproductive behavior in female and male Long-Evans rats.

AIM AND METHODS

Rats received daily 10-min sessions of electronic-cigarette vaporized nicotine (5% Virginia Tobacco JUUL Pods) or room air in a whole-body exposure chamber (postnatal day 28-31). Pubertal onset was monitored daily (ie, vaginal opening in females, preputial separation in males). Two weeks later, rats were tested for sexual motivation using the partner-preference paradigm, whereby subjects were given the opportunity to approach either a sexual partner or a same-sex social partner. Four weeks later, partner preference was assessed again, 10 min after rats were re-exposed to their same prepubertal treatment.

RESULTS

We found that prepubescent electronic-cigarette vaporized nicotine disrupted puberty and sexual motivation in female but not male rats. In vaped females, vaginal opening was delayed and less time was spent with the male stimulus compared to room-air controls. In contrast, no effect of e-cigarette vapor was observed on pubertal onset or on any measures of sexual behavior in male rats. No effects were observed in either female or male rats on the second partner-preference test.

CONCLUSIONS

Prepubescent vaporized nicotine affected the development of reproductive physiology and behavior in female rats but not in male rats, whereas an additional acute exposure to nicotine vapor had no effect in either female or male adult rats.

IMPLICATIONS

Given the prevalence of increasingly younger users, more animal research is needed to explore the effects of e-cigarette smoking on multiple developmental systems including reproductive physiology and behavior. This model could be useful in exploring multiple behavioral and physiological endpoints in both sexes. Adjustments to the duration of exposure and control conditions will be necessary for future experiments to best model human use.

Role of acetylcholine in control of sexual behavior of male and female mammals

The results of studies using systemic or central applications of cholinergic drugs suggest that acetylcholine makes important contributions to the neurochemical control of male- and female-typical reproductive behaviors. In males, cholinergic control seems largely specific to some elements or aspects of copulatory behavior that can vary significantly across species. Synapses in or near the medial preoptic area represent part of this mechanism, but the entire system appears to extend more widely, perhaps especially to one or more structures flanking some part of the lateral ventricle. In females, the lordosis response that essentially defines sexual receptivity is clearly responsive to cholinergic drugs. The same seems likely to be true of other elements of female sexual behavior, but additional studies will be needed to confirm this. Changes in cholinergic activity may help to mediate estrogenic effects on female sexual behavior. However, estrogen exposure can increase or decrease cholinergic effects, suggesting a relationship that is complex and requires further analysis. Also presently unclear is the localization of the cholinergic effects on female sexual responses. Though periventricular sites again have been implicated, their identity is presently unknown. This review discusses these and other aspects of the central cholinergic systems affecting male and female sexual behaviors.

Potential contribution of aromatase inhibition to the effects of nicotine and related compounds on the brain

Cigarette smoking continues to be a major public health problem, and while smoking rates in men have shown some decrease over the last few decades, smoking rates among girls and young women are increasing. Practically all of the important aspects of cigarette smoking and many effects of nicotine are sexually dimorphic (reviewed by Pogun and Yararbas, 2009). Women become addicted more easily than men, while finding it harder to quit. Nicotine replacement appears to be less effective in women. This may be linked to the observation that women are more sensitive than men to non-nicotine cues or ingredients in cigarettes. The reasons for these sex differences are mostly unknown. Several lines of evidence suggest that many of the reported sex differences related to cigarette smoking may stem from the inhibitory effects of nicotine and other tobacco alkaloids on estrogen synthesis via the enzyme aromatase (cyp19a gene product). Aromatase is the last enzyme in estrogen biosynthesis, catalyzing the conversion of androgens to estrogens. This review provides a summary of experimental evidence supporting brain aromatase as a potential mediator and/or modulator of nicotine actions in the brain, contributing to sex differences in smoking behavior. Additional research on the interaction between tobacco smoke, nicotine, and aromatase may help devise new, sex specific methods for prevention and treatment of smoking addiction.

Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications

Over many years a large number of studies have demonstrated that nicotine and exposure to cigarette smoke produce marked neuroendocrine changes in animals and in man. The initial effects of nicotine are characterized by a marked hypersecretion of ACTH, vasopressin, beta-endorphin, prolactin and LH. Many of these very acute stimulatory effects of nicotine rapidly disappear, probably due to a desensitization of the central nicotinic cholinergic receptors involved. Instead, upon acute intermittent treatment with nicotine or exposure to cigarette smoke, an inhibition of prolactin, LH and TSH secretion occurs, which is associated with maintained hypersecretion of corticosterone. These effects are probably mediated via activation of central cholinergic receptors of the ganglionic type. Evidence indicates that the inhibitory effects of nicotine on LH and prolactin secretion are produced via an activation by these nicotinic receptors of the tubero-infundibular dopamine neurons, releasing dopamine as a prolactin inhibitory factor. Dopamine inhibits LHRH release via an axonic interaction involving D1-like dopamine receptors in the median eminence. It therefore seems possible that the reduced fertility found in heavy smokers may be counteracted by D1 receptor antagonists. The symptoms associated with glucocorticoid hypersecretion induced by nicotine is discussed considering not only the peripheral side effects but also permanent deficits in hippocampal glucocorticoid receptors and loss of hippocampal neurons. In view of the important influence of hormones on immune functions, it seems likely that smoking will cause disturbances in immune responsiveness. Finally, the nicotine-induced alterations of neuroendocrine function, especially in the pituitary-adrenal axis and in vasopressin release, may also lead to behavioural consequences in smokers, especially in the withdrawal phase.

Cholinergic mechanisms of lordotic behavior in rats

Cholinergic mechanisms of lordotic behavior were studied in hooded rats using behavioral techniques and autoradiographic analysis of the diffusion of [3H]N methyl scopolamine ([3H]NMS) applied to the hypothalamus. Bilateral cannulae were implanted chronically in the region of the ventromedial nuclei (VMN). A series of cholinergic drugs and estradiol (E2) were administered to each rat during successively induced periods of estrus. Robust inhibition of lordosis resulted from administration of atropine and scopolamine. Robust facilitation followed carbachol administration. Pirenzepine, hexamethonium, and tetraethylammonium did not inhibit lordosis. [3H]NMS, the last drug in the series to be administered, inhibited lordosis in two of three rats. Autoradiographic analysis of [3H]NMS diffusion in these rats revealed that radioactivity was confined entirely to the hypothalamus and appeared in the region of the VMN. In an additional experiment, the in vitro binding characteristics of [3H]NMS in the basomedial hypothalamus were examined. The VMN appeared lightly labeled and were surrounded by regions of darker labeling. We conclude that cholinergic drugs influence lordotic behavior when applied in crystalline form in the vicinity of the VMN of the female rat hypothalamus.

Nicotinic cholinergic influences on sexual receptivity in female rats

Drugs which alter nicotinic cholinergic transmission were administered to female rats to examine the neurochemical regulation of feminine sexual behavior. Nicotine (50, 100 or 200 micrograms/kg, IP) facilitated lordosis behavior 5 minutes after injection in estrogen-primed ovariectomized (OVX) rats. Pretreatment with the nicotinic antagonist, mecamylamine (MECA, 2.5 or 10 mg/kg) prevented this effect, while atropine pretreatment (30 mg/kg) reduced it. Mecamylamine pretreatment also reduced lordotic behavior induced by bilateral intracerebroventricular (ICV) injection of the cholinesterase inhibitor, eserine (5 micrograms/cannula). However, MECA treatment (5 or 10 micrograms/cannula, bilaterally, ICV, or 5 or 10 mg/kg, IP) did not reduce sexual receptivity in OVX rats made highly receptive with estrogen plus progesterone priming. By comparison with previously published results, MECA is apparently less effective than muscarinic antagonists in disrupting sexual receptivity in several paradigms. There appears to be a critical muscarinic link in the neural circuit for sexual receptivity, but there does not appear to be a comparable nicotinic link. In fact, the lordosis-facilitating effect of nicotine may be a pharmacological effect unrelated to the normal neurochemical regulation of sexual receptivity.

Acute continuous exposure to cigarette smoke produces discrete changes in cholecystokinin and substance P levels in the hypothalamus and preoptic area of the male rat

By means of a Walton Horizontal Smoking Machine, male rats were exposed to the smoke from I-4 cigarettes burned in a continuous fashion. Cholecystokinin (CCK) and substance P levels (determined by means of radio-immunoassay) were measured in discrete hypothalamic and preoptic regions. Acute continuous exposure to cigarette smoke induced increases in CCK levels in the paraventricular hypothalamic region as well as decreases in CCK levels in the median eminence. Furthermore, this treatment resulted in decreased CCK and substance P levels in the medial preoptic region. The results have been interpreted to indicate that CCK and substance P containing neuronal systems can be regulated by cholinergic nicotine-like receptors.

Evoked ventromedial hypothalamic activity: changes produced by drugs which modify female sexual behavior in the rat

The effect of several pharmacologic agents on the field potential and multiunit responses evoked in the ventromedial hypothalamic nucleus (VMN) by single shocks applied to the anterior part of the amygdaloid nucleus and the posterior part of the lateral amygdaloid nucleus was investigated in ovariectomized (OVX) and proestrous (PRO) rats using a combined infusion cannula and recording electrode. The local infusion of carbamylcholine and eserine incremented the multiunitary responses, whereas atropine, hexamethonium, and hemicholinium suppressed the multiunit responses and, in the case of atropine, the field response also. The onset of the suppressive effect of hemicholinium depended on the activation of the amygdaloid input. Phenoxybenzamine, methysergide, and picrotoxin increased the multiunitary evoked responses in OVX, but phenoxybenzamine and methysergide had no effect on PRO rats. On the contrary, propanolol suppressed the response. Because a good correlation can be observed between the effects of drugs on evoked responses and on sexual behavioral responses (lordosis) of the female rat as reported in the literature, the results are compatible with the hypothesis that (a) amygdaloid influences on sexual behavior are exerted through modifications of neuron activity in the VMN, (b) this influence involves the activation of a cholinergic synapse, and (c) catecholaminergic, GABAergic, and serotoninergic inputs modulate VMN neuron responses to activity originated in the amygdala.

Inhibition of lordotic behavior in female rats following intracerebral infusion of anticholinergic agents

Cholinergic antagonists were bilaterally infused into forebrain areas of ovariectomized female rats brought into sexual receptivity by administration of estrogen and progesterone. Infusion of hemicholinium-3 (HG-3, 5 or 7.5 micrograms/cannula), an acetylcholine synthesis inhibitor believed to interfere with choline uptake, decreased the incidence of lordotic behavior displayed by females. This inhibition was prevented by infusion of choline chloride (120 micrograms/cannula) along with HC-3. Atropine sulfate, an acetylcholine receptor blocker, also reduced lordotic behavior in females following intracerebral infusion (20 micrograms/cannula). These results lend support to the suggestion that lordotic behavior is facilitated by central cholinergic activity.

Cholinergic brain mechanisms and the hormonal regulation of female sexual behavior in the rat

Cholinergic muscarinic stimulation of the medial preoptic area or the mesencephalic reticular formation with carbachol or bethanechol facilitated lordosis in ovariectomized female rats treated with estrogen. Adrenalectomy did not abolish the facilitative influence of cholinergic stimulation in the preoptic area. Implants of carbachol in the neocortex failed to increase lordosis.

On the action of nicotine and cotinine on central 5-hydroxytryptamine neurons

The actions of nicotine, and its main metabolite cotinine, on 5-hydroxytryptamine (5-HT) neurons in the brain of the rat have been assessed biochemically (on turnover, uptake, release, overflow and binding of 5-HT in brain) and functionally (on extensor reflex activity, which is 5-HT dependent). Nicotine and cotinine in repeated doses of 2 mg/kg caused a reduction of brain 5-HT turnover, which was not blocked by pretreatment with mecamylamine, and nicotine sifnificantly inhibited the effects of norfenfluramine and 5-methoxydimethyltryptamine on extensor reflex activity, effects counteracted by mecamylamine. In low concentrations cotinine weakly inhibits the uptake and retention of 5-HT and also increases its spontaneous release in vitro. The biochemical findings suggest that the reduction of 5-HT and also increases its spontaneous release in vitro. The biochemical findings suggest that the reduction of 5-HT turnover caused by high doses of nicotine are mediated, at least in part, by its main metabolite cotinine. The experiments on extensor reflexes indicate that nicotine can block the functional expression of 5-HT receptor activity in the spinal cord by an action beyond the 5-HT receptor at nicotine-like cholinergic receptors whose location is also discussed.